Secondary Infection

Also known as: Secondary infections / Secondary infection NOS / Secondary infection (disorder) / Infection / Infections / Infection NOS

Drug	Drug Name	Drug Description
DB00626	Bacitracin	A cyclic polypeptide antibiotic used to prevent wound infections, treat pneumonia and empyema in infants, and to treat skin and eye infections.
DB00954	Dirithromycin	An antibiotic used to treat a variety of respiratory, skin, and other infections.
DB00591	Fluocinolone acetonide	A corticosteroid used to treat skin conditions, eczematous otitis externa, diabetic macular edema, and non-infectious uveitis of the posterior segment of the eye.
DB13092	Meclocycline	A tetracycline antibiotic indicated in the treatment of susceptible skin infections, bacterial vaginitis, vulvovaginitis, and cervicitis.

Drug	Drug Name	Target	Type
DB00626	Bacitracin	Alpha-2-macroglobulin	target
DB00626	Bacitracin	Insulin-degrading enzyme	target
DB00626	Bacitracin	C55-isoprenyl pyrophosphate	target
DB00626	Bacitracin	Bacitracin transport ATP-binding protein BcrA	transporter
DB00626	Bacitracin	Bacitracin transport permease protein BCRB	transporter
DB00626	Bacitracin	Bacitracin transport permease protein BcrC	transporter
DB00954	Dirithromycin	23S ribosomal RNA	target
DB00954	Dirithromycin	Cytochrome P450 3A4	enzyme
DB00591	Fluocinolone acetonide	Corticosteroid-binding globulin	carrier
DB00591	Fluocinolone acetonide	Glucocorticoid receptor	target
DB00591	Fluocinolone acetonide	Cytochrome P450 3A4	enzyme
DB00591	Fluocinolone acetonide	Annexin A1	target
DB00591	Fluocinolone acetonide	Annexin A2	target
DB00591	Fluocinolone acetonide	Annexin A3	target
DB00591	Fluocinolone acetonide	Annexin A4	target
DB00591	Fluocinolone acetonide	Annexin A5	target
DB00591	Fluocinolone acetonide	Phospholipase A2	target
DB13092	Meclocycline	Outer membrane protein F	transporter
DB13092	Meclocycline	Outer membrane porin C	transporter
DB13092	Meclocycline	30S ribosomal protein S7	target
DB13092	Meclocycline	TetX family tetracycline inactivation enzyme	enzyme

Drug	Drug Name	Phase	Status	Count
DB01256	Retapamulin	4	Completed	1